A July 2026 UT Southwestern preclinical study shows EGFR inhibitor pretreatment may sensitize glioblastoma to chemo. Rural patients face barriers to this type of specialized care.
A New Glioblastoma Research Finding Highlights an Older Problem: Rural Brain Cancer Patients Often Can’t Access the Care That Would Help Them
by | Jul 24, 2026 | Uncategorized | 0 comments
Recent Comments